Dec 20, 2013, 06.00 PM IST
Arvind Bothra, vice president of institutional research at Religare Capital Markets is positive on Aurobindo Pharma. "Its US business is continuing to do exceedingly well, both on execution of product launches as well as the quality of product approvals," he adds.
Tags Arvind Bothra, Religare Cap Mkts, Aurobindo Pharma, Aurobindo Pharm, Lupin, Sun Pharma
Like this story, share it with millions of investors on M3
Arvind Bothra positive on Aurobindo Pharma
Arvind Bothra, vice president of institutional research at Religare Capital Markets is positive on Aurobindo Pharma. "Its US business is continuing to do exceedingly well, both on execution of product launches as well as the quality of product approvals," he adds.
Like this story, share it with millions of investors on M3
Arvind Bothra positive on Aurobindo Pharma
Arvind Bothra, vice president of institutional research at Religare Capital Markets is positive on Aurobindo Pharma. "Its US business is continuing to do exceedingly well, both on execution of product launches as well as the quality of product approvals," he adds.
He further added, "The second thing which is more important for Aurobindo has been steady improvement in cash flows and profitability which has led to reduction in debt levels in the last two quarters by close to USD 110 million."
"In the near-term they have benefited from Cymbalta product opportunity or Duloxetine where initial expectations were to have 8-10 players on day one whereas only Aurobindo, Lupin and Sun Pharma have been able to launch so far. So the opportunity suddenly becomes much more lucrative than it was anticipated and from Aurobindo's base that would be a significant positive," Bothra said.
He further said, "We have seen consistent earnings improvement in the first half, you would see even stronger second half for Aurobindo. So I remain positive and though it is not in my active coverage list, but I have been tracking the stock and I am positive on the stock at these levels."
Anda sedang membaca artikel tentang
Arvind Bothra positive on Aurobindo Pharma
Dengan url
http://harmonisem.blogspot.com/2013/12/arvind-bothra-positive-on-aurobindo.html?m=0
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Arvind Bothra positive on Aurobindo Pharma
namun jangan lupa untuk meletakkan link
Arvind Bothra positive on Aurobindo Pharma
sebagai sumbernya
0 komentar:
Posting Komentar